Participation of people with haemophilia in clinical trials of new treatments: An investigation of patients' motivations and existing barriers

Blood Transfusion

Volumn 13, Issue 2, 2015, Pages 302-309

  Henrard, Séverine ^a,b   Speybroeck, Niko ^a   Hermans, Cedric ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Clinical research; Haemophilia; Patients' motivation; Survey

Indexed keywords

NEW DRUG;

ADULT; ARTICLE; CLASSIFICATION; CLINICAL RESEARCH; CONTROLLED STUDY; GENE THERAPY; HEMOPHILIA A; HEMOPHILIA B; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MOTIVATION; PATIENT EDUCATION; PATIENT PARTICIPATION; PHARMACEUTICAL CARE; PROPHYLAXIS; QUESTIONNAIRE; RANDOM FOREST; RESPONSE VARIABLE; AGE; CLINICAL TRIAL (TOPIC); FEMALE;

ADULT; AGE FACTORS; CLINICAL TRIALS AS TOPIC; FEMALE; HEMOPHILIA A; HUMANS; MALE; MIDDLE AGED; MOTIVATION; PATIENT PARTICIPATION; SURVEYS AND QUESTIONNAIRES;

EID: 84927557529     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2014.0152-14     Document Type: Article

References (10)

1. Darby SC, Kan SW, Spooner RJ, et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007;110:815-25.
2. Young G. New challenges in hemophilia: long-term outcomes and complications. ASH Education Program Book 2012(1):362-8.
3. Shapiro AD, Soucie JM, Peyvandi F, et al. Knowledge and therapeutic gaps: a public health problem in the rare coagulation disorders population. Am J Prev Med 2011;41:S324-31.
4. DiMichele DM, Blanchette V, Berntorp E. Clinical trial design in haemophilia. Haemophilia 2012;18(Suppl 4):18-23.
5. Lassila R, Armstrong E. Current challenges of pharmacovigilance in bleeding disorders: converting the burden to benefit. Haemophilia 2010;16:231-7.
6. Mannucci PM. Evolution of the European guidelines for the clinical development of factor VIII products: little progress towards improved patient management. Haemophilia 2013;19:344-8.
7. Ragni MV, Moore CG, Bias V, et al. Challenges of rare disease research: limited patients and competing priorities. Haemophilia 2012;18:e192-4.
8. Speybroeck N. Classification and regression trees. Int J Public Health 2012;57:243-6.
9. Mills EJ, Seely D, Rachlis B, et al. Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol 2006;7:141-8.
10. Ross S, Grant A, Counsell C, et al. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol 1999;52:1143-56.